What we found on the web about Multiple Myeloma
Multiple myeloma - Wikipedia, the free encyclopedia
Multiple myeloma (from myelo-, bone marrow), also known as MM, myeloma, plasma cell myeloma, or as Kahler's disease (after Otto Kahler) is a cancer of the white blood cells known ...
Multiple Myeloma Research Foundation - Wikipedia, the free ...
The Multiple Myeloma Research Foundation (MMRF) was founded in 1998 by twin sisters Kathy Giusti and Karen Andrews following Kathy's diagnosis with multiple myeloma at the age of ...
Multiple Myeloma Research Center -- Cleveland Clinic
Multiple Myeloma is part of plasma cell dyscrasia. Research at the Cleveland clinic is focused on developing drugs as Thalidomide, Revlimid, Lenalidomide, Bortezomib, Velcade and ...
Multiple Myeloma: WHAT IS MULTIPLE MYELOMA?
Information and services for everyone battling multiple myeloma, a cancer of the bone marrow for which there is currently no known cure. Check out our research grant program.
Multiple Myeloma: eMedicine Radiology
Overview: Multiple myeloma is the most common primary neoplasm of the skeletal system. The disease is a malignancy of plasma cells. Radiologically, multiple destructive lesions ...
ACS :: What Is Multiple Myeloma?
Multiple myeloma is a type of cancer formed by malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system.
Articles, News and Information on Multiple Myeloma (MM)
Multiple myeloma (MM) is a type of cancer that causes abnormalities in the plasma cells. Read on for articles, news and information on multiple myeloma.
Multiple Myeloma: eMedicine Hematology
Overview: Multiple myeloma is a debilitating malignancy that is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance (MGUS) to plasma cell ...
Multiple Myeloma Causes, Diagnosis, Symptoms, and Treatment on ...
Learn more about multiple myeloma, a form of cancer that develops in plasma cells, the white blood cells that make antibodies. Symptoms include bone pain, weakness, extreme thirst ...
Multiple Myeloma Clinical Trials
The Myeloma Institute for Research and Therapy is committed to accelerating curative therapies for Multiple Myeloma and related disease entities through innovative clinical and ...
Multiple Myeloma/Other Plasma Cell Neoplasms - National Cancer ...
Information about multiple myeloma and other plasma cell neoplasms: treatment, clinical trials, research, and statistics from the National Cancer Institute.
Leukemia & Lymphoma Society - Myeloma
This is often called multiple myeloma. A mass of myeloma cells is called a "plasmacytoma." A plasmacytoma can form in the bone, skin, muscle, lungs or any other part of the body.
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Multiple Myeloma

Multiple myeloma (from myelo-, bone marrow), also known as MM, myeloma, plasma cell myeloma, or as Kahler's disease (after Otto Kahler) is a cancer of the white blood cells known as plasma cells, which produce antibodies.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Multiple Myeloma
Gloucester Pharma nets $1.7M in latest funding
Mass High Tech
According to an announcement from last December, Gloucester Pharmaceuticals saw positive interim results from a Phase 1/2 combination study of romidepsin, Velcade and dexamethasone in patients with relapsed or refractory multiple myeloma. A...
FDA approves sNDA for pediatric autism drug ABILIFY
News-Medical-Net
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irr...
As Proteolix Finds, Luck Plays A Big Role In Biotech
Wall Street Journal
Carfilzomib, which may earn accelerated U.S. approval for relapsed and refractory multiple myeloma, has a low incidence of peripheral neuropathy, or damage to the nerves, according to the company. Peripheral neuropathy is one potential side...
Mount Sinai nephrologist on helping kidneys go the distance
New York Daily News
Others at high risk are patients with lupus and multiple myeloma cancer, and those with a family history of kidney disease. But everyone should be aware of the threat, says Radbill. "Some people have chronic kidney disease without any of th...
Nerat expected back on job soon
Escanaba Daily Press
In a press release issued in August, Nerat stated she had been diagnosed with multiple myeloma. She underwent treatment at Froedtert Hospital in Milwaukee. During that time, questions concerning state government were directed to her staff m...
Amy Elizabeth Neuls, 39
The Herald-Mail
Amy Elizabeth Neuls, 39, of Frederick, Md., and Hagerstown, Md., passed away due to complications of multiple myeloma on Monday, Nov. 16, 2009, at Frederick Memorial Hospital, in the loving presence of her family.
Millennium Initiates First Clinical Trial With The First Oral Proteasome Inhibitor
Medical News Today
Millennium: The Takeda Oncology Company announced it has further expanded its protein homeostasis program with the initiation of a Phase I clinical trial for an oral formulation of MLN9708, the Company's second-generation proteasome inhibit...
Interim data from Geron's ongoing imetelstat trial presented at the AACR-NCI-EORTC conference
News-Medical-Net
Geron Corporation today announced the presentation of interim data from its ongoing trial of imetelstat (GRN163L), a telomerase inhibitor drug, in patients with refractory, advanced solid cancers at the 2009 AACR-NCI-EORTC International Con...